OCLASSEN PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
OCLASSEN PHARMACEUTICALS, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CONDYLOX. The owner is based in CORTE MADERA, CA.
201 TAMAL VISTA BLVD.
CORTE MADERA, CA 94925
Showing of trademarks Trademarks
Trademark Classifications
OCLASSEN PHARMACEUTICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does OCLASSEN PHARMACEUTICALS, INC. have?
OCLASSEN PHARMACEUTICALS, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned, 6 cancelled.
What trademark classes does OCLASSEN PHARMACEUTICALS, INC. file in?
OCLASSEN PHARMACEUTICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are OCLASSEN PHARMACEUTICALS, INC.'s most well-known trademarks?
OCLASSEN PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as CONDYLOX. These are among 1 currently registered trademark in the portfolio.
What is OCLASSEN PHARMACEUTICALS, INC.'s trademark registration success rate?
OCLASSEN PHARMACEUTICALS, INC. has a 8% trademark registration rate, with 1 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.